Subsequently, TAMs suppress cytotoxic T cell responses through the production of Arg1, programmed death-ligand 1 (PD-L1), and IL-10, allowing tumors to evade anti-tumor immunity (Gordon and Martinez, 2010). The gene discussed is IL10; the disease is neoplasm.